Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,846,615
+$51,204 QoQ
Shares Held
7,271
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#2,421
of 4,664 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Houlihan Financial Resource Group, Ltd. holds $4,447,659 across 5 Drug Manufacturers - General names. JNJ ranks #1 (41.5% of the industry book) .
All Filings in JNJ
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,846,615 | 7,271 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,795,411 | 7,345 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,519,013 | 7,340 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $582,404 | 3,141 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,152,498 | 7,545 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,235,342 | 7,449 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,077,852 | 7,453 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,289,997 | 7,960 | Shares | Sole | 2024-11-01 | |
| 2024-03-31 | $1,278,807 | 8,084 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,290,126 | 8,231 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,283,847 | 8,243 | Shares | Sole | 2023-11-09 | |
| 2023-03-31 | $1,289,135 | 8,317 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,480,503 | 8,381 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,369,120 | 8,381 | Shares | Sole | 2022-12-13 | |
| 2020-09-30 | $1,422,399 | 9,554 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $1,238,129 | 9,442 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||